Edition:
United States

People: Evogene Ltd (EVGN.OQ)

EVGN.OQ on NASDAQ Stock Exchange Global Market

2.91USD
18 May 2018
Change (% chg)

$0.09 (+3.19%)
Prev Close
$2.82
Open
$2.86
Day's High
$2.91
Day's Low
$2.86
Volume
1,351
Avg. Vol
3,027
52-wk High
$5.76
52-wk Low
$2.66

Karchi, Hagai 

Dr. Hagai Karchi serves asExecutive Vice President and Chief Technology Officer at Evogene Ltd. since 2004. He is co-founder of Evogene Ltd. He served as the Company's CEO from 2002 until 2004. Prior to the spin-off of Evogene Ltd. from Compugen Ltd. he was the Co-Head of Compugen's Plant Genomic Division. He has over 15 years experience in the breeding of tomatoes and in molecular genomics research. His scientific achievements include the development of a molecular system for gene discovery and the development of high yielding, high quality greenhouse tomato varieties. Dr. Karchi has lectured widely in the field of plant genomics and has several publications. Dr. Karchi holds B.Sc and M.Sc degrees in Genetics from the Hebrew University of Jerusalem’s Faculty of Agriculture, specializing in gene expression. He also holds a joint Ph.D. degree in Genetics from The Weizmann Institute of Science, Israel.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --